Pacific Biosciences Of California (PACB) Interest Expenses (2012 - 2026)
Pacific Biosciences Of California (PACB) recorded quarterly Interest Expenses of $1.7 million in Q1 2026, little changed quarter-over-quarter from $1.7 million in Q4 2025, and little changed on a YoY basis from $1.7 million in Q1 2025.
Pacific Biosciences Of California (PACB) Interest Expenses (2012 - 2026) Analysis & Trends
Pacific Biosciences Of California's Interest Expenses history runs 15 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Interest Expenses changed 0.17% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $7.0 million (down 39.89% YoY), while the FY2025 annual figure was $7.0 million, down 48.15% from the prior year.
- Interest Expenses was $1.7 million for Q1 2026 at Pacific Biosciences Of California, roughly flat from $1.7 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $3.7 million in Q1 2022 to a low of $1.7 million in Q1 2025.
- Historically, Interest Expenses has averaged $3.0 million across 5 years, with a median of $3.6 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses soared 106.65% in 2022, then tumbled 51.41% in 2025.
- A 5-year view of Interest Expenses shows it stood at $3.6 million in 2022, then retreated by 2.11% to $3.6 million in 2023, then retreated by 22.79% to $2.8 million in 2024, then slumped by 36.89% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
- The last three Interest Expenses figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn | 1.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.74 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Sep 30, 2024 | 3.54 Mn |
| Sep 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 3.54 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 3.57 Mn |
| Dec 31, 2023 | 3.57 Mn |